Community Center

Cardiologist at Mayo Clinic. Former junior #Musketeer. #amyloidosis and #echo. Tweets limited to medicine and #Xavier basketball. My own and not my employer's.

Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company's singular mission is…

Dr. Suzanne Lentzsch, MD, PhD. Director of the Multiple Myeloma and Amyloidosis Service at Columbia University Medical Center.

Nephros is a commercial stage medical device company that develops and sells high-performance liquid purification filters. Nephros filters capture contaminants as…

Stanford IM residency program director, Cardiologist, Specialist in Amyloidosis, Cardio-Oncology, and Advanced heart failure.

BSIM's mission is to deliver quality drug candidates with high capital efficiency against transthyretin-mediated amyloidosis, including clinical manifestations and…

Twitter Handle: Director, Cardiac Amyloidosis Program, Brigham and Women's Hospital and Harvard Medical School.

SOM Biotech is a clinical-stage drug discovery and development company based in Barcelona, Spain, with an office in the US, focused on repurposing drugs for CNS…

The official Twitter for the Brigham and Women's Hospital Amyloidosis Program.

Prothena Corporation plc is a clinical-stage neuroscience company focused on the discovery and development of novel therapies with the potential to fundamentally…